Company profile for PhysIQ

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

PhysIQ (pronounced Phys-IQ) is healthcare’s first personalized physiology data analytics platform. PhysIQ is designed to track and integrate multiple vital signs to detect clinically meaningful changes against an individual baseline, rather than a population-based “norm.” Our founders pioneered PhysIQ’s game-changing data analytics platform for mission-critical machine applications. We are now focused on the most impor...
PhysIQ (pronounced Phys-IQ) is healthcare’s first personalized physiology data analytics platform. PhysIQ is designed to track and integrate multiple vital signs to detect clinically meaningful changes against an individual baseline, rather than a population-based “norm.” Our founders pioneered PhysIQ’s game-changing data analytics platform for mission-critical machine applications. We are now focused on the most important machine of all — the human body.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
200 W Jackson Blvd, Chicago, IL 60606
Telephone
Telephone
800.516.7902
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercebiotech.com/cro/oncobay-signs-physiqs-latest-clinical-trial-partner-program

FIERCEBIOTECH
17 Nov 2022
PhysIQ unveils partner program for CROs, other research groups
PhysIQ unveils partner program for CROs, other research groups

10 Nov 2022

// Joseph Keenan FIERCEBIOTECH

https://www.fiercebiotech.com/cro/physiq-unveils-new-partner-program-cros-other-research-groups

Joseph Keenan FIERCEBIOTECH
10 Nov 2022

https://www.businesswire.com/news/home/20221109005832/en

BUSINESSWIRE
09 Nov 2022
InCarda, PhysIQ and Syneos team for phase 3 flecainide study
InCarda, PhysIQ and Syneos team for phase 3 flecainide study

31 Aug 2022

// Joseph Keenan FIERCEBIOTECH

https://www.fiercebiotech.com/cro/incarda-physiq-and-syneos-team-phase-3-flecainide-study

Joseph Keenan FIERCEBIOTECH
31 Aug 2022

https://www.businesswire.com/news/home/20220824005139/en

BUSINESSWIRE
24 Aug 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty